Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease

QR Code

Klotho allele status is not associated with Aß and APOE e4–related cognitive decline in preclinical Alzheimer's disease

© 2019 Elsevier Inc. The longevity gene Klotho (KL), specifically the functional KL-VS variant, has previously been associated with cognition and rates of cognitive decline. This study aimed to determine whether KL-VS associations with cognition were observable in preclinical Alzheimer's diseas...

Full description

Bibliographic Details
Main Authors:	Porter, T., Burnham, S., Milicic, L., Savage, G., Maruff, P., Lim, Y., Ames, D., Masters, C., Martins, R., Rainey-Smith, S., Rowe, C., Salvado, O., Groth, David, Verdile, Giuseppe, Villemagne, V., Laws, S.
Format:	Journal Article
Published:	Elsevier Inc. 2019
Online Access:	http://hdl.handle.net/20.500.11937/73742

Similar Items

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aß-amyloid burden
by: Porter, T., et al.
Published: (2018)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease
by: Porter, T., et al.
Published: (2018)

Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
by: Porter, T., et al.
Published: (2018)

ß-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men
by: Holmes, S., et al.
Published: (2016)

BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF
by: Lim, Y., et al.
Published: (2017)

Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner
by: Gardener, S., et al.
Published: (2017)

Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
by: Pike, K., et al.
Published: (2011)

APOE-E4 and APOE-491A polymorphisms in individuals with subjective memory loss
by: Laws, S., et al.
Published: (2002)

Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
by: Burnham, S., et al.
Published: (2016)

Longitudinal cognitive decline in the AIBL cohort: The role of APOE e4 status
by: Albrecht, Matthew, et al.
Published: (2015)

Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status
by: Foster, J., et al.
Published: (2014)

Alleles of apolipoprotein E gene (APOE) as genetic determinants of dementia
by: Akter, Seikh Farid Uddin, et al.
Published: (2012)

Aß aggregation and possible implications in Alzheimer's disease pathogenesis
by: Bharadwaj, Prashant, et al.
Published: (2009)

Effects of latrepirdine on Aß clearance, neurotoxicity and aggregation
by: Martins, R., et al.
Published: (2010)

Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults
by: Laws, S., et al.
Published: (2017)

Latrepirdine enhances Aß degradation in yeast via an autophagic pathway
by: Bharadwaj, Prashant, et al.
Published: (2010)

Amyloid ß–associated cognitive decline in the absence of clinical disease progression and systemic illness
by: Harrington, K., et al.
Published: (2017)

African-American TOMM40'523-APOE haplotypes are admixture of West African and Caucasian alleles
by: Roses, A., et al.
Published: (2014)

Effect of chronic hCG administration on Alzheimer's-related cognition and Aß accumulation in PS1KI mice
by: Barron, A., et al.
Published: (2010)

The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)

Plasma Aß42 correlates positively with increased body fat in healthy individuals
by: Balakrishnana, K., et al.
Published: (2005)

Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study
by: Holmes, S., et al.
Published: (2018)

Oligomerization and toxicity of Aß fusion proteins
by: Caine, J., et al.
Published: (2011)

The Effects of Latrepirdine on Amyloid-ß Aggregation and Toxicity
by: Porter, T., et al.
Published: (2016)

Modulation of Amyloid Beta (Aß) Structure and Toxicity by a Dairy-derived Peptide Product
by: Bennett, L., et al.
Published: (2010)

Association of alleles carried at TNFA -850 and BAT1 -22 with Alzheimer's disease
by: Gnjec, A., et al.
Published: (2008)

Allelic diversity of S‑RNase alleles in diploid potato species
by: Dzidzienyo, Daniel Kwadjo, et al.
Published: (2016)

The Concept of Integrating Virtual Group (VG) and Agile Supplier Selection (ASS)
by: Farzad, Tahriri, et al.
Published: (2010)

Associations between gonadotropins, testosterone and [beta] amyloid in men at risk of Alzheimer’s disease
by: Verdile, Giuseppe, et al.
Published: (2014)

Influence of coding variability in APP-Aß metabolism genes in sporadic Alzheimer's disease
by: Sassi, C., et al.
Published: (2016)

The immuno localisation of aplipoproteins B-48 (APO B-48) and B-100 (APO B-100) in human tissues
by: Mohd Esa, Norhaizan, et al.
Published: (2001)

Preclinical safety evaluation of WJMSCs and their secretome
by: Premasangery Kathivaloo,, et al.
Published: (2025)

Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies
by: Martins, R., et al.
Published: (2018)

Intimal retention cholesterol derived from apoB48 and apoB100-containing lipoproteins in carotid arteries from WHHL rabbits.
by: Proctor, Spencer, et al.
Published: (2003)

Erratum: Clearance mechanisms of Alzheimer's amyloid-? peptide: Implications for therapeutic design and diagnostic tests (Molecular Psychiatry (2009) 14 (469-486) DOI: 10.1038/mp.2008.96)
by: Bates, K., et al.
Published: (2009)

Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
by: Bates, K., et al.
Published: (2009)

Altered levels of serum haptoglobin and apo A-I in schizophrenia
by: Tze Jen Chow,, et al.
Published: (2011)

Development of cordycepin formulations for preclinical and clinical studies
by: Lee, Jong Bong, et al.
Published: (2017)

Expanding the repertoire of gene tools for precise manipulation of the Clostridium difficile genome: allelic exchange using pyrE alleles
by: Ng, Yen K., et al.
Published: (2013)

Cerebral glucose metabolism is associated with verbal not visual performance in community-dwelling older adults
by: Gardner, S., et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_539t6qvc39d969ts1tvb64p564